
Blake Vanderhyde, Esq.
Advisor to Arobella Medical, LLC
Blake Vanderhyde is the President of Vanderhyde Consulting, Inc., where he leads initiatives to advance innovative technologies. His focus is on strategic planning, growth acceleration, and developing actionable roadmaps. He is also the Founder of Vanderhyde Law, a law practice specializing in mass tort litigation.
Blake graduated summa cum laude from Saint Cloud State University in Minnesota and earned his law degree from William Mitchell College of Law, where he served on the Law Review. He is licensed to practice in both state and federal courts and has been recognized by organizations such as Super Lawyers, Minnesota Law, and Who’s Who in Politics.
He has been an active member of several professional associations, including the American Association for Justice, Minnesota Association for Justice, Minnesota State Bar Association, Hennepin County Bar Association, Delta Theta Phi Law Fraternity International, and the American Inns of Court – Minnesota, Douglas Amdahl Inn.
Copyright © 2026 Superbug Treatments - The Future of Medicine? - All Rights Reserved.
FULL DISCLOSURE: This website is provided for informational and educational purposes only. It does not constitute an offer to sell securities, a solicitation of interest in any securities offering, medical advice, or investment advice. Certain statements in this article may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that could cause actual results to differ materially, including but not limited to: failure of in vivo scientific validation, adverse FDA classification or pathway decisions, inability to secure development financing, unforeseen competitive developments, regulatory changes, and loss of key inventor knowledge. The antimicrobial applications discussed here are investigational and are not FDA-cleared for antimicrobial indications. As of the date of publication, no legal entity has been formed or identified for purposes of any securities offering related to this technology. Any future financing, if any, would be conducted only through formal offering materials and in compliance with applicable federal and state securities laws. Do not rely on this content for investment, legal, or medical decisions.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.